Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clazosentan in aneurysmal subarachnoid hemorrhage (CONSCIOUS-2)
NCT00558311Phase 3Completed
- Sponsor
- Idorsia
- Start
- Dec 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of clazosentan in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Idorsia. Started Dec 2007; status: completed.
02
Drugs
clazosentan
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00558311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558311.